Bloomer
Bloomer is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Bloomer.
Frequently Asked Questions
Who founded Bloomer?
Bloomer was founded by Armindo Costa (Co-Founder).
Bloomer is a company.
Key people at Bloomer.
Bloomer was founded by Armindo Costa (Co-Founder).
Bloomer was founded by Armindo Costa (Co-Founder).
Key people at Bloomer.
Bloomer Tech is a healthcare technology company focused on improving cardiovascular health for women through innovative wearable medical devices. Their flagship product is the world’s first electrocardiogram (ECG) device embedded in a bra, using patented medical-grade fabric sensors and machine learning to provide continuous, comfortable heart monitoring. This product serves women of all shapes, sizes, and ages, addressing the critical problem of underrepresentation of women in cardiovascular research and the lack of female-specific heart health data. Bloomer Tech’s solution empowers women with real-time heart health insights, enabling personalized care and better disease management. The company has demonstrated strong growth momentum, winning notable awards such as the NHLBI SBIR Phase 2 award in 2023 and the Innovation Pitch Challenge at ACC.24 in 2024[1][3].
Founded in 2017 by Alicia Chong Rodriguez and Aceil Halaby, both MIT alumnae, Bloomer Tech emerged from the founders’ recognition of a significant gender gap in cardiovascular research and diagnostics. They aimed to create a device that women would want to wear daily, replacing uncomfortable traditional ECG devices with a stylish, functional garment. Early traction came from their innovative approach to combining textile technology with AI, leading to partnerships and recognition from institutions like the National Heart, Lung, and Blood Institute (NHLBI)[3].
Bloomer Tech rides the growing trend of personalized digital health and wearable medical devices, particularly in the femtech sector. The timing is critical as cardiovascular disease remains the leading cause of death among women, yet women have been historically underrepresented in clinical research. Market forces such as increasing demand for gender-specific healthcare solutions, advances in AI, and wearable technology adoption favor Bloomer’s growth. The company influences the broader ecosystem by pushing for more inclusive data collection and personalized care models, potentially reshaping cardiovascular diagnostics and research paradigms[1][3].
Bloomer Tech is poised to expand its product line to cover a wider range of heart-related conditions and demographics, including monitoring factors like menstrual cycles to enhance cardiovascular care. Future trends shaping their journey include the integration of AI-driven personalized medicine and the growing emphasis on women’s health equity. Their influence is likely to grow as they continue to break down barriers between patient care, research, and daily life, empowering women with ownership of their health data and improving outcomes in cardiovascular disease management[3].
